What's new

Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 2, Status: Authorised

May 5, 2025 - 14:37
 0
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Andaz Miami Beach is now officially open!

Next Article

Human medicines European public assessment report (EPAR): Deltyba, delamanid, Da...

Related Posts

First treatment against severe thyroid eye disease

First treatment against severe thyroid eye disease

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Segluromet, ertugliflozin,metformin hydrochloride, Date of authorisation: 23/03/2018, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

May 2, 2025  0

Industry annual bilateral meetings

Industry annual bilateral meetings

Apr 29, 2025  0